Presentations

35 years of modelling and simulation

Jongh J. de. 35 years of modelling and simulation as robust tools in drug development From terminal half-life to quantitative and translational systems pharmacology. 22nd MDO / 33rd JSSX, 2018.

Development of a mathematical model to elucidate the cross- linking of GSK1995057 and ADAs and binding to TNFR1 receptor

Steeg T.J.v., Keunecke A., Fairman D. Development of a mathematical model to elucidate the cross- linking of GSK1995057 and ADAs and binding to TNFR1 receptor – filling the gap between hypothesis and reality. PAGE, 2018. [Link to publication]

A Perspective on integrating Pharmacometrics and Quantitative Systems Pharmacology characteristics

Trame M.N., Post T.M. Session 1c:  A Perspective on integrating Pharmacometrics and Quantitative Systems Pharmacology characteristics using examples. ACoP9, 2018.  [Link to publication]

Application of an iPSP Model

Post T.M. Application of an iPSP Model with Reduced Mechanistic Detail for a Disease System Analysis applied to Osteoporosis. ACoP9, 2018. [Link to publication]

Tutorial 1: nlmixr: Population Modeling in R

Fidler M., Wang W., Post T.M., Wilkins J., Schoemaker R., Trame M.N. Tutorial 1:  nlmixr: Population Modeling in R. ACoP9, 2018. [Link to publication]

Solving sensitivity equations by inductive linearization and its applications in population pharmacokinetic and pharmacodynamic models via FOCEi

Fidler M, Xiong Y, Schoemaker R, Wilkins J, Trame M.N, Post T.M, Hooijmaijers R, Wang W., Solving sensitivity equations by inductive linearization and its applications in population pharmacokinetic and pharmacodynamic models via FOCEi. ACoP9 2018

Exploring inductive linearization in population pharmacokinetic and pharmacodynamic models

Fidler M, Xiong Y, Schoemaker R, Wilkins J, Trame M.N, Post T.M, Hooijmaijers R, Wang W. Exploring inductive linearization in population pharmacokinetic and pharmacodynamic models. ACoP9, 2018.

Evaluate the effect of intrinsic and extrinsic factors on regorafenib (REG) exposure

Ploeger B., Cleton A., Keunecke A., Bruix J., Meinhardt G. Population pharmacokinetics (popPK) to evaluate the effect of intrinsic and extrinsic factors on regorafenib (REG) exposure in REG studies including patients with hepatocellular carcinoma (HCC). The American Society of Clinical Oncology – Gastrointestinal Cancers Symposium, 2017.

Systems pharmacology analysis of the Aβ oligomer response following β-secretase inhibition

Maanen E.M.T.v., Steeg T.J.v., Kalinina J., Michener M.S., Savage M.J., Kennedy M.E., Parker E.M., Danhof M. Systems pharmacology analysis of the Aβ oligomer response following β-secretase inhibition: Evidence for second-order kinetics of Aβ42 oligomerization. AAIC, 2017.

A systems pharmacology approach unfolds Aβ oligomer modulation

Maanen E.M.T.v., Steeg T.J.v., Kalinina J., Michener M.S., Savage, M.J., Kennedy M.E., Parker E.M., Danhof, M. A systems pharmacology approach unfolds Aβ oligomer modulation and unravels the dynamics of the APP pathway. Page 2017. [Link to publication]